Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Increasing number of orthopedic surgeries is an important factor driving growth of the global bone regeneration materials market. According to the National Center for Biotechnology Information, in 2015, around 7,076 hospital admissions for total knee arthroplasties (TKAs) and 13,017 hospital admission for total hip arthroplasties (THAs) were reported in Brazil. Moreover, in 2015, the state of Sao Paulo registered 49% geriatrics in the Southeast region of Brazil, among which accounted 47.4% for TKAs and 53.8% for THAs.
Similarly, the increasing incidence of osteoarthritis among the global population is expected to drive growth of global bone regeneration materials market during the forecast period. According to data published by the Arthritis Foundation in November 2017, arthritis was the leading cause of disability among adults in the U.S. Over 53 million adults worldwide suffered from arthritis, which included over 100 types of joint diseases. This is expected to increase 49% to reach over 78.4 million by 2040.
Moreover, the increasing demand for allografts, xenografts, and various other synthetic bone grafts that are innovative substitutes for real bones is expected to facilitate the market growth. For instance, use of hydroxyapatite in bone grafts without any organic and biological agents obstructs natural processes such as osteogenesis, osteoconduction, and osteoinduction, as they are made through recombinant DNA technology.
Global Bone Regeneration Materials Market - Impact of Coronavirus (COVID-19) Pandemic
The spread of the novel coronavirus has hampered growth of the healthcare industry. In December 2019, in China’s Wuhan City, a cluster of pneumonia cases were reported by Chinese health authorities. The pneumonia causative agent was identified as a novel coronavirus named COVID-19. This virus spread rapidly across the globe, thus causing a concerning number of fatalities. In March, 2020, the World Health Organization (WHO) declared the COVID-19 as a global pandemic and suggested implementation of strict measures to minimize the spread of this disease. The pandemic has slowed down growth of the healthcare sector and led to a disturbance in the supply chain.
Moreover, governments across various countries have implemented nationwide lockdowns to curb the spread of COVID-19. Similarly, in various countries across the world, healthcare companies are facing problems of continuing its supply chain operations. The slowdown of the healthcare companies’ supply chain has also impacted growth of Global Bone Regeneration Materials Market.
Global bone regeneration materials market is estimated to be valued at US$ 2292.1 million in 2020 and is expected to exhibit a CAGR of 3.3% during the forecast period (2020-2027).
Fig.1. Global Bone Regeneration Materials Market Share (%) Analysis, By Product Type, 2020
Global Bone Regeneration Materials Market- Restraints
The global bone regeneration materials market growth is expected to be hampered by the risks associated with surgery failure and graft failure can act as a potential barrier to growth of this market. For instance, as per results of Dental-Implants-01, the dental bone graft failure rates range ranges from 5-10% on an average, as a result of infections and improper stabilization of the grafts. Therefore, failure in implantation may hinder growth of bone regeneration material market.
Global Bone Regeneration Materials Market: Opportunities
Development of new regenerative techniques is expected to offer lucrative growth opportunities for players in the market. For instance, simple hip decompression is a new regenerative technique for patients with early-stage osteonecrosis of the hip. It is a less invasive outpatient procedure in which a surgeon makes a small hole outside the hip and taps into the diseased area.
Adoption of 3D printing technology in regenerative therapies is expected to aid in growth of the global bone regeneration materials market. For instance, in February 2020, researchers from Wake Forest School of Medicine, U.S. reported investigation of the effects of neural cell integration into the bioprinted skeletal muscle construct to accelerate functional muscle regeneration in vivo.
Bone Regeneration Materials Market Report Coverage
||Market Size in 2020:
||US$ 2292.1 Mn
|Historical Data for:
||2017 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 2877.0 Mn
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
- By Product Type: Xenogene Bone Materials, Partially Synthetic Materials, Synthetic Materials, Others.
- By Application: Orthopaedic Surgery, Bone Trauma, Dental Surgery, Others.
Sigma Graft, NovaBone, B&B Dental, Stryker Corporation, J Morita USA, Kerr Restoratives, Septodont, Citagenix, and Ethoss Regeneration Ltd.
- The increasing number of orthopedic surgeries
|Restraints & Challenges:
- Risks associated with surgery failure and graft failure can act as a potential barrier to growth of this market.
Global Bone Regeneration Materials Market – Regional Analysis
On the basis of region, the global bone regeneration materials market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to witness significant growth in the global bone regeneration materials market, owing to the increasing geriatric population and research studies in the field of tissue engineering. For instance, in August 2018, bioengineers at the Pennsylvania State University developed a composite ink to 3-D print porous, bone-like constructs. The materials showed biologically favorable interactions in the laboratory, followed by positive outcomes of bone regeneration in an animal model in vivo.
Additionally, the increasing geriatric population which is more prone to degenerative disorders such as osteoarthritis, in the U.S. is expected to propel growth of the global bone regeneration materials market in the region. For instance, according to the Centers for Disease Control and Prevention (CDC), July 2018 data findings, from 2013-2015, around 54.4 million U.S. adults (22.7% of total U.S. population) suffered from some form of arthritis such as rheumatoid arthritis, gout, lupus, or fibromyalgia annually.
Europe is also expected to witness potential growth in the global bone regeneration materials market, owing to increasing focus on gene therapy forbone regeneration. For instance, the European Union’s Horizon 2020 research and innovation programme has launched cmRNAbone a novel gene therapy for bone regeneration project in January 2020. The project aims to develop a novel bone regenerative therapy for trauma and osteoporosis patients. The researchers planned to develop chemically modified RNAs and a specific vector delivery system to be in a biomaterial formulation tailored to patients’ needs. The project is partnered with 11 organization of different countries. Over the next four years, partners of this project will receive around US$ 7.47 million funding from the European Union’s Horizon 2020 Framework Programme.
Fig.2. Global Bone Regeneration Materials Market Value (US$ mn) & Y-o-Y Growth (%), 2017-2027
Global Bone Regeneration Materials Market- Competitive Landscape
Key players operating in the global bone regeneration materials market are Sigma Graft, NovaBone, B&B Dental, Stryker Corporation, J Morita USA, Kerr Restoratives, Septodont, Citagenix and Ethoss Regeneration Ltd.